티앤알바이오팹
2,005KRWMarket close of 10/21 (Wed)
Down -0.74%-15KRWMarket close of 10/21 (Wed)
- Open
- 2,050
- High
- 2,070
- Low
- 2,000
- Day range
- Day range low 2,000 high 2,070, open 2,050, close 2,005, previous close 2,020
- Volume
- 14×10K shares
- 276.92 million KRW 1.04× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
24%1-year close range 1,194 to 4,535 won, 24% up from the low
24% of the way up from the lowest close in 1 year (252 sessions) · -55.8% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-6.4B KRWOperating income over the last four quarters -6.4B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move-0.74%usual range
- Trading value1.0×usual range
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue8.7B KRW
- vs. year ago
- +46.5%
- vs. prior quarter
- +16.0%
- Operating income-931.34 million KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-10.7%
- vs. year ago
- +49.4 pp
- vs. prior quarter
- +19.8 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-08-27Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.